1 / 48

SICU Combine meeting

SICU Combine meeting. 2012-4-26 蔡壁 如. Case Presentation. 56yr, Male: CAD s/p POBAS with ICMP s/p heterotopic heart transplantation in 2004 Hypertension Gout CRI

haruko
Download Presentation

SICU Combine meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SICU Combine meeting 2012-4-26 蔡壁如

  2. Case Presentation • 56yr, Male:CAD s/p POBAS with ICMP s/p heterotopic heart transplantation in 2004 • Hypertension • Gout • CRI • Current Medication:Burinex 1 mg/tab 1 tab BID SR Diltelan SR 120 mg/cap 1 capFolic Acid 5 mg/tab 1 tab QD PO Allopurinol 100 mg/tab 1 tab BID PO Colchicine 0.5 mg/tab 1 tab BID PO SandimmunNeoral 25 mg/cap 2 cap BID POCellCept 250 mg/cap 2 cap BID PO

  3. ER 2012-1-25 • At ER, afebrile but SpO293% with short of breath. • EKG monitor showed intermittent VT. • Cardiac echo showed poor recipient heart with LVEF:23% • LV systolic function is normal with LVEF:61.6%. • BUN, Creand potassium was 118, 6.06 and 7.9(H9). •  Under the impression of acute kidney injury, suspected rejection or infection-related

  4. 2012-1-26 start RRT • AKI Cause • Sepsis ? • Rejection ? • Both?  Acute on chronic ?

  5. 問題一：重症透析的人工膜選擇 5008HF Stenotrophomonasmaltophilia 1/30, 2/8, 2/10, 2/15

  6. 問題二：急性腎損傷透析液的選擇

  7. Unveiling Current Controversies inAcute Kidney Injury Kellum JA, Ronco C, Vincent J- L (eds): Controversies in Acute Kidney Injury. ContribNephrol. Basel, Karger, 2011, vol 174, pp1–3

  8. Dialyzer membranes for RRT in AKI 2012 KDIGO guideline for AKI

  9. Dialyzer membranes for RRT in AKI

  10. Hemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: a Prospective randomized multicenter trial 人工膜:1.2m2

  11. Low-Flux vs High Flux Synthetic Dialysis Membrane in Acute Renal Failure : Prospective Randomized Study • In conclusion, no significant differences were found in the results of low-flux versus high-flux synthetic membrane dialyzer treatment in patient in terms of survival rate, recovery of renal function, ……. • Low-flux synthetic polysulphone dialyzer (1.3 m2) vs High-flux synthetic AN-69(1.3m2) Artif Organs, Vol 25, No. 12, 2001

  12. Membranes for Dialysis and Hemofiltration --- 7.3 • Management of Acute Kidney Problems • D. H. Krieter and C. Wanner. 2010 •  Materials : Synthetic membrane √ •  Low-flux vs High-flux •  Size

  13. High-flux vs Low-flux • The Hemodialysis (HEMO) study • not find a difference between low- and high-flux membranes Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO Study. J Am SocNephrol 2003 14:3251-3263. • MPO study ( Membrane Permeability Outcome) • High-flux benefits in DM and low serum albumin levels (< 4 g/dl) • No significant survival benefit Membrane Permeability Outcome (MPO) Study Group Effect of membrane permeability on survival of hemodialysis patients. J Am SocNephrol2009 20:645-654

  14. No study was able to demonstrate differences in survival between low- and high-flux membranes. • Is the choice of membrane important for patients with acute renal failure requiring hemodialysis? 1995 ArtifOrgans 19:391-394. • Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. 2000 Mayo Clin Proc 75: 1141- 1147. • Comparison of cellulose diacetateand polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. 2000 NephrolDial Transplant 15:224- 230 • Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: prospective randomized study. 2001 ArtifOrgans 25:946-950. • Only with respect to the recovery of renal function that a possible advantage of high- over low-flux membranes. • (2000) Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc 75: 1141- 1147. • Biocompatible hemodialysis membranes for acute renal failure. 2008 Cochrane Database SystRev 23:CD005283

  15. Modality of ARRT with Efficiency Defined Marshall MR, Golper TA:Semin Dial 24:142-148,2011

  16. Low-Efficiency Acute Renal Replacement Therapy : Role in Acute Kidney Injury • PIRRT effect of urea disequilibrium on time concentration profiles  inbound and rebound • 1.8 m2 low-flux(QB200, QD100, 12HR)  4% rebound • 1.8 m2 low-flux (QB200, QD500, 8hr) 17% rebound • High-efficiency PIRRT • Unacceptable Disequilibrium Mark R. Marshall*† and Thomas A. Golper • Seminars in Dialysis—Vol 24, No 2 (March–April) 2011 pp. 142–148

  17. Low-Efficiency Acute Renal Replacement Therapy : Role in Acute Kidney Injury

  18. Low-Efficiency Acute Renal Replacement Therapy : Role in Acute Kidney Injury three major ways in which solute disequilibrium affects the clinical care of patients: • ARRT dose • dialysis disequilibrium syndrome • hemodynamic instability

  19. solute disequilibrium • Symptoms of headache, disorientation and nausea at its mildest, delirium, myoclonus ⁄ seizures and coma at its most severe. • The pathogenesis is incompletely understood although it is clearly attributable to cerebral edema from water influx as the final common pathway Ronco C, Bellomo R, KellumJ. Critical Care Nephrology. 2009:1079–1083

  20. Low-Efficiency Acute Renal Replacement Therapy : Role in Acute Kidney Injury • Prosaic Use of Lower-Efficiency ARRT • Low-flux membrane • Lower-efficiency

  21. Case Presentation • 52yrs, AMI with ventricular septal rupture status post repairmen of ventricular septum on 2012/01/07, • Tachypnea and agitation were noted around 8PM on 2/19, and desaturation to 90% was found. CXR showed pulmonary edema, r/o pneumonia, and BW gain>7Kg , metabolic acidosis with dopamine infusion, he was transferred to ICU. And start CRRT. • 2/20 5008HF(standard setting), BUN/Cre:283/5.79  2/23 BUN/Cre :33/1.83 • solute disequilibrium ??? • 停止透析:2012/3/4

  22. Case Presentation • 35yrs, DCMP with congestive heart failure and lung edema s/p ECMO support(2012/3/22), s/p LVAD support (2012/03/26) • 3/28 septic shock  start RRT (SLED 2hr due to BUN/Cre:174/4.91, prevent disequilibrium?) • 3/28 night profound acidosis  5008HF • 3/29 Expired

  23. 超過濾係數 Ultrafiltration Coefficient • Low (Standard) Flux • UFcoefficient 2-9 ml/mmHg/hour • Intermediate Flux • UFcoefficient 10-19 ml/mmHg/hour • High Flux • UFcoefficient 20-80 ml/mmHg/hour • 水份的移除 (Hydraulic Permeability)  超過濾係數Kuf • (ml/mmHg/hour)

  24. Categories for HD membranes Vicken J. Membranes in Haemodialysis in；Peinemann KV, Pereira Nunes SP, (eds) Membranes for Life Sciences. Wiley Co, 2007；1-48.

  25. 血液透析器設計理念 血液過濾器設計理念 血液透析過濾器 for SLEDD-f

  26. 血液透析器 for IHD Chronic Filter 200 µm 40 µm

  27. 血液透析器設計理念 血液過濾器設計理念 血液透析過濾器 for SLEDD-f

  28. “理想的" 血液過濾（Hemofilter） • 具高生物相容性 • 具良好的中大分子篩濾與清除效果 • 抗凝劑需要量越低越好 • 最少可連續使用24小時

  29. “理想的" 血液過濾器 • Function • Membrane permeability • Diffusion Low flux and High flux • Convention High flux • Filter and Fiber Geometry • Adapted for low blood flow • Large ID：short • Biocompatibility

  30. 血液過濾器 – 中空纖維特性 Membrane geometry adapted to special needs in CRRT • Decreased wall thickness • increased diffusive clearance • Increased inner lumen • less shear-stress • lower thrombogenicity • lower heparin need Acute Filter 35 µm 220 µm

  31. 血液透析器設計理念 血液過濾器設計理念 血液透析過濾器 for SLEDD-f

  32. S i e v i n g C o e f f i c i e n t 1 , 0 0 , 8 S t a n d a r d m e m b r a n e P o l y s u l f o n e Ultra - F l u x K i d n e y 0 , 6 0 , 4 0 , 2 0 100 1000 100000 10000 10 I n u l i n ß 2 - M A l b u m i n V i t . B U r e a C r e a t i n i n e 1 2 M o l e c u l a r W e i g h t [ D a l t o n ] high-flux dialyzer is required to SLEDD-f • A high-flux dialyser is required to perform SLEDD-f • A dialysis membrane with high hydraulic permeability, high solute permeability and large surface exchange • Moderate transmembrane pressures (< 300mmHg) • Simultaneously avoid or minimal albumin loss • Highly biocompatible membrane is particular importance The cut off of the membrane is ~ 30.000 Dalton.

  33. Membranes for Dialysis and Hemofiltration --- 7.3 Dialysis membranes should have： • high diffusive and convective clearances for the removal of a wide range of toxins. • the best possible biocompatibility to avoid undesirable interactions with blood components • adequate hydraulic permeability for use in intermittent or continuous renal replacement therapy modes • the highest pyrogenretention capability for the use with non-ultrapure dialysate.

  34. Membrane Size • 早期: 1.2 m2 • 近期: 1.4 ~ 1.8 m2

  35. SICU Dialysis indication

  36. SICU Dialysis method 選一種人工腎臟：兼顧PIRRT and IHD ？ CRRT:1.4 m2 AV-600

  37. 台大AK

  38. AN-69 : Bradykininrelease syndrome

  39. J Am SocNephrol 20: 645–654, 2009

  40. J Am SocNephrol 20: 645–654, 2009

More Related